ICD-10 Coding for Dementia with Agitation Treated with Seroquel
For a patient with dementia and agitation being treated with Seroquel (quetiapine), use F03.91 (Unspecified dementia with behavioral disturbance) as your primary diagnosis code, which captures both the underlying dementia and the behavioral/agitation component that justifies antipsychotic use.
Understanding the Coding Framework
The ICD-10 code F03.91 specifically identifies:
- F03 = Unspecified dementia
- .91 = With behavioral disturbance (which includes agitation, aggression, combative behavior, and wandering)
This code is appropriate because it documents the clinical justification for using an antipsychotic medication like Seroquel in a dementia patient—namely, the presence of behavioral disturbances requiring pharmacological intervention.
Alternative Coding Options Based on Dementia Type
If you know the specific dementia etiology, use these more specific codes:
- F01.51: Vascular dementia with behavioral disturbance
- G30.9 + F02.81: Alzheimer's disease with behavioral disturbance (requires two codes)
- F02.81: Dementia in other diseases classified elsewhere with behavioral disturbance
Critical Documentation Requirements
When using Seroquel for dementia-related agitation, your documentation must justify antipsychotic use per APA guidelines 1:
Document that the agitation is:
- Severe, dangerous, and/or causing significant patient distress
- Not responsive to or assessed for nonpharmacological interventions first
- Warranting the risks of antipsychotic treatment after risk/benefit discussion
Include in your notes:
- Specific behavioral symptoms (frequency, severity, pattern, timing)
- Assessment for pain and other modifiable contributors
- Discussion of risks/benefits with patient or surrogate decision maker
- Plan for reassessment after 4 weeks and consideration of tapering
Important Clinical Caveats
Black Box Warning Context: The FDA label explicitly states that Seroquel is not approved for dementia-related psychosis due to increased mortality risk 2. Using F03.91 documents the off-label indication while capturing the clinical scenario that led to prescribing.
Avoid These Coding Pitfalls:
- Don't use F03.90 (dementia without behavioral disturbance)—this contradicts your use of an antipsychotic for agitation
- Don't code only the dementia without the behavioral component—payers may question medical necessity
- Don't use psychosis codes unless psychotic symptoms are actually present and documented
Safety Monitoring: Recent evidence shows low-dose quetiapine in older adults carries increased risks of mortality, dementia progression, and falls 3. Your coding should support documentation of ongoing monitoring and reassessment, as the APA recommends tapering after 4 weeks if no response or when side effects emerge 1.
The behavioral disturbance modifier (.91) is essential for justifying antipsychotic use in this vulnerable population where benefits are modest and risks are substantial 1, 4.